I’ve been tracking the global spread of biotechnology for quite a while now. I’m fascinated with why biotechnology has taken root so strongly in the United States while many other countries are struggling to develop critical mass. This is the topic of a paper I’ve recently co-submitted in response to a request from the American Institute for Contemporary German Studies, where they are comparing German and American histories in biotechnology. More details will follow once the publication posts.
In the meantime, I’ve been cited by the AP in an article on the global expansion of biotech R&D. Just as manufacturing and back-office jobs have been offshored, the same is happening for biotech R&D. It’s interesting to watch, and should have profound implications for the cost structure of the industry.